Cathay Biotech Inc.
688065.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥23 | CN¥32 | CN¥36 | CN¥55 |
| - Cash | CN¥5 | CN¥5 | CN¥6 | CN¥10 |
| + Debt | CN¥2 | CN¥2 | CN¥1 | CN¥1 |
| Enterprise Value | CN¥19 | CN¥28 | CN¥31 | CN¥46 |
| Revenue | CN¥3 | CN¥2 | CN¥2 | CN¥2 |
| % Growth | 39.9% | -13.4% | 3.3% | – |
| Gross Profit | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Margin | 28.3% | 27.4% | 34% | 35.4% |
| EBITDA | CN¥1 | CN¥0 | CN¥1 | CN¥1 |
| % Margin | 23% | 21.3% | 27.5% | 28.3% |
| Net Income | CN¥0 | CN¥0 | CN¥1 | CN¥1 |
| % Margin | 16.5% | 17.3% | 22.7% | 25.2% |
| EPS Diluted | 0.84 | 0.63 | 0.95 | 1.43 |
| % Growth | 33.3% | -33.7% | -33.6% | – |
| Operating Cash Flow | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Capital Expenditures | -CN¥1 | -CN¥2 | -CN¥4 | -CN¥1 |
| Free Cash Flow | -CN¥0 | -CN¥1 | -CN¥3 | -CN¥1 |